Glenmark Pharmaceuticals has received final USFDA for Tacrolimus ointment used for treating atopic dermatitis (eczema). The ointment is a generic version of Protopic ointment, of Leo Pharma AS in the same strength. According to market estimates, Protopic ointment 0.1 per cent a market potential of US$ 109 million per annum.
Company Profile : Glenmark Pharma Ltd
Leave a Reply